Increase in Research and Development Costs Associated with LSI Miniaturization
First written in FY2016. 3 of 17 entries say "Worsened", first in FY2016. Latest entry: FY2026.
Axell moved to the "Worse" side of this theme in 2026, 5 years after the typical company in this theme (2021).
The whole theme swung hardest in 2019: 4 of 13 companies on the "Worse" side.
6 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「Our Group also focuses on the research and development of various LSI products using advanced processes, and LSI development costs have increased as the processes used become more advanced and feature sizes decrease. Historical consolidated R&D expenses were ¥1,579 million for the fiscal year ended March 2024, ¥1,547 million for the fiscal year ended March 2025 and ¥1,641 million for the fiscal year ending March 2026.」
The company explicitly identifies higher development costs resulting from miniaturization, and R&D expenses changed from ¥1,547 million in the previous fiscal year to ¥1,641 million. - 2026-05-11WorsenedFinancial results briefing materials
「R&D expenses 1,547 53% 1,641 54% 93 6% / Of which, net development expenses 311 11% 397 13% 86 28%」
R&D expenses increased 6% year on year and net development expenses increased 28%, indicating higher development-related spending. - FY2025Disclosed annual R&D expenses of ¥1,547 millionAnnual report
「Historical consolidated R&D expenses were ¥1,552 million for the fiscal year ended March 2023, ¥1,579 million for the fiscal year ended March 2024 and ¥1,547 million for the fiscal year ended March 2025.」
In connection with the risk of higher development costs resulting from miniaturization, the company discloses R&D expenses of ¥1,547 million for the fiscal year ended March 2025. - FY2025-H1Disclosed interim R&D expenses of ¥697 millionAnnual report
「R&D expenses included in selling, general and administrative expenses were ¥697 million, a decrease of ¥83 million, or 10.7%, from the same interim period of the previous year.」
As historical results related to R&D costs associated with LSI miniaturization and other factors, the company discloses R&D expenses of ¥697 million for the interim consolidated accounting period. - FY2024Disclosed full-year R&D expenses of ¥1,579 millionAnnual report
「Historical consolidated R&D expenses were ¥1,520 million for the fiscal year ended March 2022, ¥1,552 million for the fiscal year ended March 2023 and ¥1,579 million for the fiscal year ended March 2024.」
In connection with R&D costs associated with LSI miniaturization, the company discloses that R&D expenses were ¥1,579 million for the fiscal year ended March 2024. - FY2023Disclosed full-year R&D expenses of ¥1,552 millionAnnual report
「Historical consolidated R&D expenses were ¥1,472 million for the fiscal year ended March 2021, ¥1,520 million for the fiscal year ended March 2022 and ¥1,552 million for the fiscal year ended March 2023.」
In connection with R&D costs associated with LSI miniaturization and other factors, the company discloses that R&D expenses were ¥1,552 million for the fiscal year ended March 2023. - FY2023-Q3Disclosed third-quarter R&D expenses of ¥1,206 millionAnnual report
「R&D activity expenses for the third quarter cumulative period were ¥1,206 million. There were no material changes in the status of the Group’s R&D activities during the third quarter cumulative period.」
In connection with R&D costs associated with LSI miniaturization and other factors, the company discloses R&D activity expenses of ¥1,206 million for the third quarter cumulative period. - FY2023-Q2Disclosed second-quarter R&D expenses of ¥770 millionAnnual report
「R&D activity expenses for the second quarter cumulative period were ¥770 million.」
The company discloses ¥770 million as the result for the second quarter cumulative period in relation to R&D costs. - FY2023-Q1Disclosed first-quarter R&D expenses of ¥456 millionAnnual report
「R&D activity expenses for the first quarter cumulative period were ¥456 million.」
The company discloses ¥456 million as the first-quarter cumulative result for R&D costs. - FY2022Disclosed annual R&D expenses of ¥1,520 millionAnnual report
「Historical R&D expenses were ¥1,549 million on a consolidated basis for the fiscal year ended March 2020, ¥1,472 million on a consolidated basis for the fiscal year ended March 2021 and ¥1,520 million on a consolidated basis for the fiscal year ended March 2022.」
As historical R&D costs associated with LSI miniaturization and other factors, the company discloses R&D expenses of ¥1,520 million for the fiscal year ended March 2022. - FY2022-Q3Third-quarter R&D expense disclosureAnnual report
「R&D expenses included in selling, general and administrative expenses were ¥921 million, a decrease of ¥169 million, or 15.5%, from the same quarter of the previous year.」
In connection with the risk of higher R&D costs resulting from LSI miniaturization, the company discloses R&D expenses of ¥921 million for the third quarter cumulative period. - FY2022-Q2Second-quarter R&D expenses updatedAnnual report
「R&D activity expenses for the second quarter cumulative period were ¥540 million.」
In connection with the risk of higher R&D costs resulting from LSI miniaturization, the company discloses R&D expenses of ¥540 million for the second quarter cumulative period. - FY2021-Q2Second-quarter R&D expense disclosureAnnual report
「R&D activity expenses for the second quarter cumulative period were ¥738 million.」
In connection with the risk of higher R&D costs resulting from LSI miniaturization, the company discloses R&D expenses of ¥738 million for the second quarter cumulative period. - FY2021-Q1Disclosure of quarterly R&D expensesAnnual report
「R&D activity expenses for the first quarter cumulative period were ¥260 million.」
In connection with the risk of higher R&D costs resulting from LSI miniaturization, the company discloses R&D activity expenses of ¥260 million for the first quarter cumulative period. - FY2020Disclosure of historical R&D expensesAnnual report
「Historical R&D expenses were ¥2,134 million for the fiscal year ended March 2018, ¥2,513 million for the fiscal year ended March 2019 and ¥1,549 million on a consolidated basis for the fiscal year ended March 2020.」
The company reiterates the risk of higher R&D costs resulting from miniaturization and discloses consolidated R&D expenses of ¥1,549 million for the first fiscal year on a consolidated basis. - FY2017RestatedAnnual report
「We focus primarily on the research and development of various LSI products using advanced processes, and LSI development costs have been trending upward as the processes used become more advanced and feature sizes decrease. Development costs are expected to increase further as the processes used become more advanced and feature sizes decrease.」
The company reiterates the trend toward higher development costs resulting from LSI miniaturization and the prospect of further increases. - FY2016WorsenedAnnual report
「We focus primarily on the research and development of various LSI products using advanced processes, and LSI development costs have been trending upward as the processes used become more advanced and feature sizes decrease. Development costs are expected to increase further as the processes used become more advanced and feature sizes decrease.」
The company identifies the upward trend in development costs resulting from miniaturization, and the prospect of further increases, as a risk.